02:25:51 Europe / Stockholm

Kurs & Likviditet

Kursutveckling och likviditet under dagen för detta pressmeddelande

Prenumeration

Kalender

2025-02-21 Bokslutskommuniké 2024
2024-08-09 Halvårsrapport
2024-06-13 Årsstämma
2024-05-02 X-dag ordinarie utdelning BONEH 0.00 EUR
2024-02-26 Bokslutskommuniké 2023
2023-10-23 Extra Bolagsstämma 2023
2023-08-25 Halvårsrapport
2023-05-02 X-dag ordinarie utdelning BONEH 0.00 EUR
2023-04-28 Årsstämma
2023-02-24 Bokslutskommuniké 2022
2022-08-25 Halvårsrapport
2022-04-29 X-dag ordinarie utdelning BONEH 0.00 EUR
2022-04-28 Årsstämma
2022-03-17 Extra Bolagsstämma 2022
2022-02-24 Bokslutskommuniké 2021
2021-08-25 Halvårsrapport
2021-04-29 X-dag ordinarie utdelning BONEH 0.00 EUR
2021-04-28 Årsstämma
2021-02-24 Bokslutskommuniké 2020
2020-08-31 Halvårsrapport
2020-04-06 X-dag ordinarie utdelning BONEH 0.00 EUR
2020-04-05 Årsstämma
2020-03-20 Bokslutskommuniké 2019
2019-08-30 Halvårsrapport
2019-04-08 X-dag ordinarie utdelning BONEH 0.00 EUR
2019-04-05 Årsstämma
2018-08-30 Halvårsrapport
2018-03-29 Årsstämma

Beskrivning

LandFinland
ListaFirst North Finland
SektorHälsovård
IndustriMedicinteknik
BBS-Bioactive Bone Substitutes är verksamt inom medicinteknik. Bolaget designar, utvecklar och konstruerar biologiska implantat för patienter med benfel och läkningsbesvär. Bolagets lösningar vidaresäljs under varumärket Artebone och baseras på tricalciumfosfat (TCP) och benprotein, som stimulerar benläkningsprocessen. Bolaget grundades under 2003 och har sitt huvudkontor i Oulu.
2023-12-19 09:30:00

BBS-Bioactive Bone Substitutes Plc, Company announcement, Management transactions, 19 December 2023 at 10.30 a.m. (EEST)

BBS-Bioactive Bone Substitutes Oyj - Managers' Transactions – Juliusz Rakowski

____________________________________________

Person subject to the notification requirement

Name: Rakowski, Juliusz

Position: CEO

Issuer: BBS-Bioactive Bone Substitutes Oyj

LEI: 743700BYSBP0PCR6N767

Notification type: INITIAL NOTIFICATION

Reference number: 743700BYSBP0PCR6N767_20231218153158_7

____________________________________________

Transaction date: 2023-12-18

Venue not applicable

Instrument type: SHARE

ISIN: FI4000260583

Nature of the transaction: SUBSCRIPTION

Transaction details

(1): Volume: 25,000 Unit price: .4 EUR

Aggregated transactions

(1): Volume: 25,000 Volume weighted average price: .4 EUR


For more information, please contact:

Juliusz Rakowski, CEO
+358 50 448 5132
juliusz.rakowski@bbs-artebone.fi

Certified Advisor:
Nordic Certified Adviser AB,
+46 70 551 67 29,
info@certifiedadviser.se


BBS in brief

BBS -Bioactive Bone Substitutes Plc is a orthobiology company that started its operations in 2003. We have developed a new product for the treatment of complex bone fractures and bone healing issues. Our goal is to provide next-generation medical products for the treatment of bone injuries in orthopedic surgery. In the pharmaceutical industry, the development and research work require perseverance and courage to innovate. We have a track record of over 20 years in this field. Our company is characterized by expertise, innovation, and dedicated employees who are passionate about their work. Our first developed product, ARTEBONE® Paste, is in the final stages of the CE marking process to enable its commercialization in the EU market. We are based in Oulu with a medical manufacturing facility in Reisjärvi, holding a manufacturing license. The company's headquarters are in Oulu, and we employ over 20 people.

BBS has been listed on Nasdaq First North Growth Market Finland since February 2018.

More information: www.bbs-artebone.fi